Homecare Self-Monitoring Devices

Global Homecare Self-Monitoring Devices Market to Reach US$7.6 Billion by 2030

The global market for Homecare Self-Monitoring Devices estimated at US$6.2 Billion in the year 2024, is expected to reach US$7.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Blood Pressure Monitors, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Blood Glucose Monitors segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 6.5% CAGR

The Homecare Self-Monitoring Devices market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Homecare Self-Monitoring Devices Market – Key Trends & Drivers Summarized

Why Are Homecare Self-Monitoring Devices Transforming Chronic Disease Management?
Homecare self-monitoring devices are playing a pivotal role in shifting healthcare from hospital-centric models to patient-centered care at home. These devices enable individuals to track vital health parameters such as blood pressure, blood glucose, oxygen saturation, ECG, temperature, and weight—allowing for early detection, real-time monitoring, and timely intervention. As chronic diseases such as hypertension, diabetes, cardiovascular disorders, and respiratory conditions continue to rise globally, these tools are becoming essential for managing long-term health without constant clinical visits.

The convergence of digital health, miniaturized electronics, and mobile connectivity is empowering patients to take control of their care through accurate, user-friendly, and portable monitoring solutions. Aging populations, especially in developed economies, are driving demand for at-home health tracking devices that can integrate with electronic health records (EHRs) and telemedicine platforms. These tools not only improve compliance and self-awareness but also reduce hospital readmission rates, making them invaluable to both patients and health systems focused on value-based care.

How Are Innovations in Technology and Connectivity Improving Diagnostic Accuracy and Accessibility?
Advancements in biosensor technology, wireless communication, and cloud-based analytics are drastically enhancing the functionality and precision of homecare self-monitoring devices. Continuous glucose monitors (CGMs), wearable ECG patches, and cuffless blood pressure monitors now offer real-time, non-invasive tracking with medical-grade accuracy. Bluetooth and Wi-Fi-enabled devices automatically sync data with mobile apps or provider dashboards, enabling trend analysis, alerts, and remote clinician review.

Artificial Intelligence (AI) is being incorporated to personalize health insights, detect anomalies, and recommend actionable interventions. Devices are becoming more intuitive, with features like voice prompts, touchscreen interfaces, and multilingual support, making them accessible to a broader user base, including the elderly and low-literacy populations. Battery life improvements, rechargeable designs, and wireless charging are also enhancing ease of use and long-term reliability. These innovations are turning home-based health tracking into a scalable, mainstream model of preventive care.

Where Is Adoption Rising Across Patient Populations and Healthcare Ecosystems?
Adoption is highest among patients managing chronic illnesses such as diabetes, heart failure, COPD, and hypertension, where regular parameter monitoring is critical. Elderly users represent a growing demographic due to the high prevalence of age-related conditions and preference for home-based care. Caregivers and family members are also key user groups, increasingly relying on these devices to monitor loved ones remotely, especially when professional care is limited.

Healthcare providers, insurers, and government agencies are integrating these tools into care coordination strategies to improve outcomes and reduce long-term costs. Remote patient monitoring (RPM) programs are rapidly expanding in both private and public sectors, enabling reimbursement-backed distribution of FDA-cleared and CE-marked devices. Demand is also rising in emerging markets, where mobile-first strategies and decentralized healthcare models are bridging access gaps. The integration of homecare devices into broader telehealth and digital therapeutics ecosystems is further cementing their role in modern care delivery.

The Growth in the Homecare Self-Monitoring Devices Market Is Driven by Several Factors…
It is primarily driven by the global rise in chronic diseases, the aging population, and a broader shift toward home-based care models. The increasing affordability and miniaturization of medical-grade sensors are making devices more accessible and comfortable for everyday use. At the same time, the expansion of reimbursement policies and RPM billing codes in key markets is incentivizing both patients and providers to adopt remote monitoring technologies.

Integration with smartphones, cloud platforms, and wearable ecosystems is enabling real-time health data tracking and proactive intervention, improving outcomes while reducing care costs. Advances in wireless communication, AI-based analytics, and digital therapeutics are creating a robust ecosystem that supports predictive, personalized healthcare at home. Furthermore, global health crises like COVID-19 have accelerated the normalization of self-monitoring, highlighting its role in managing infectious and chronic conditions alike. These combined forces are driving the sustained growth and technological evolution of the homecare self-monitoring devices market.

SCOPE OF STUDY:

The report analyzes the Homecare Self-Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Blood Pressure Monitors, Blood Glucose Monitors, SPO2 Monitoring Kit, ECG Machines, Sleep Testing Device, Other Types); Device Type (Wearable, Handheld, Other Device Types); Application (Metabolic Disorders, Circulatory Disorders, Respiratory Track Disorder, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Abbott Laboratories
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer Healthcare
• Cofoe Medical Technology Co. Ltd
• Contec Medical Systems Co., Ltd.
• F. Hoffmann-La Roche Ltd
• GE HealthCare
• Guardian Connect (Medtronic)
• HELYXON HealthCare Solutions Pvt Ltd
• InBody Co., Ltd.
• KARABINIS MEDICAL SA
• LifeScan, Inc.
• Medtronic plc
• MIR Medical International Research
• OMRON Healthcare Co., Ltd.
• Pylo Health
• ResMed Inc.
• VitalTracer Ltd.
• Withings

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.